In Reply

Affiliations

Comment

A Dhanya Mackeen et al. Obstet Gynecol. 2018 Apr.

. 2018 Apr;131(4):744.

doi: 10.1097/AOG.0000000000002557.

¹ Department of Obstetrics and Gynecology, Geisinger Medical Center, Danville, Pennsylvania.

No abstract available

Comment on

Foley Plus Oxytocin Compared With Oxytocin for Induction After Membrane Rupture: A Randomized Controlled Trial.
Mackeen AD, Durie DE, Lin M, Huls CK, Qureshey E, Paglia MJ, Sun H, Sciscione A. Mackeen AD, et al. Obstet Gynecol. 2018 Jan;131(1):4-11. doi: 10.1097/AOG.0000000000002374. Obstet Gynecol. 2018. PMID: 29215519 Clinical Trial.
Foley Plus Oxytocin Compared With Oxytocin for Induction After Membrane Rupture: A Randomized Controlled Trial.
Abraham C. Abraham C. Obstet Gynecol. 2018 Apr;131(4):744. doi: 10.1097/AOG.0000000000002556. Obstet Gynecol. 2018. PMID: 29578975 No abstract available.

1. Mackeen AD, Durie DE, Lin M, Huls CK, Qureshey E, Paglia MJ, et al. Foley plus oxytocin compared with oxytocin for induction after membrane rupture: a randomized controlled trial. Obstet Gynecol 2018;131:4–11.
1. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999;94:274–8.
1. Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol 1991;164:1317.